• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    34.49 Down 0.19(0.55%) Apr 17, 4:00PM EDT
    |After Hours : 34.49 0.00 (0.00%) Apr 17, 4:37PM EDT
    Add to Portfolio
    Prev Close:34.68
    Open:34.50
    Bid:33.50 x 200
    Ask:N/A
    1y Target Est:44.73
    Beta:1.32
    Next Earnings Date:30-Apr-15ACOR Earnings announcement
    Day's Range:33.71 - 34.88
    52wk Range:28.26 - 45.45
    Volume:623,511
    Avg Vol (3m):739,024
    Market Cap:1.44B
    P/E (ttm):82.12
    EPS (ttm):0.42
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ACORDown 0.55%1.44B
    BIIBDown 2.15%98.41B
    TEVAUp 2.24%55.29B

    Key Statistics

    Forward P/E (1 yr):37.09
    P/S (ttm):3.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.49
    Quarterly EPS Est (Mar-15) :0.11
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):2.22

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback